Skip to main content
. 2019 Nov 1;8(6):1. doi: 10.1167/tvst.8.6.1

Table 1.

CDR-L1 and CDR-L2 Sequences of Designed Ranibizumab Variants

Fab
CDR-L1
CDR-L2
pI
Fv HI
Ranibizumab WT SASQDISNYLN FTSSLHS 8.1 1212
RBZ–3 SASQDISNYLN DTSDLES 6.8 1163
RBZ+7 RARQGIRNYLN KTSRRHS 10.2 1009
RBZ-HI low QASQDISNSLN STSNLHS 8.9 1165
RBZ-HI high SVSQVISSWLA FASSLQT 9.1 1296